BG
Gilbert, Benoît Thomas P.
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Gut microbiome and intestinal inflammation in preclinical stages of rheumatoid arthritis | RMD open |  | 2024 | 92 | 25 | ||
| Comparative effectiveness of baricitinib and alternative biological DMARDs in a Swiss cohort study of patients with RA | BMJ open | | 2024 | 102 | 36 | ||
| Maternal obesity increases the risk of hepatocellular carcinoma through the transmission of an altered gut microbiome | JHEP reports | | 2024 | 120 | 45 | ||
| Brief report: can COVID-19 infection trigger rheumatoid arthritis-associated autoimmunity in individuals at risk for the disease? A nested cohort study | Frontiers in medicine | | 2023 | 54 | 41 | ||
| A potential role for chlamydial infection in rheumatoid arthritis development | Rheumatology | | 2023 | 68 | 73 | ||
| Gut microbiome in the development of rheumatoid arthritis | | 2023 | 264 | 457 | |||
| Characterization of serum biomarkers and antibody responses against Prevotella spp. in preclinical and new-onset phase of rheumatic diseases | Frontiers in cellular and infection microbiology | | 2023 | 86 | 44 | ||
| Brief report : assessment of mucosal barrier integrity using serological biomarkers in preclinical stages of rheumatoid arthritis | Frontiers in immunology | | 2023 | 160 | 97 | ||
| Periodontitis in first degree-relatives of individuals with rheumatoid arthritis: a short narrative review | Frontiers in oral health | | 2022 | 179 | 59 | ||
| Peut-on prédire la polyarthrite rhumatoïde ? | Revue du rhumatisme monographies |  | 2022 | 92 | 0 | ||
| Global epidemiology of rheumatoid arthritis | Nature reviews. Rheumatology | | 2022 | 282 | 1 | ||
| Cohort profile: SCREEN-RA: design, methods and perspectives of a Swiss cohort study of first-degree relatives of patients with rheumatoid arthritis | BMJ Open | | 2021 | 263 | 100 | ||
| Associations between serum antibodies to periodontal pathogens and preclinical phases of rheumatoid arthritis | Rheumatology | | 2021 | 242 | 0 | ||
| Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab | RMD open | | 2021 | 236 | 74 | ||
| Associations between gut microbiota and genetic risk for rheumatoid arthritis in the absence of disease: a cross-sectional study | The Lancet. Rheumatology | | 2020 | 203 | 155 | ||
| Measuring ACPA in the general population or primary care: is it useful? | RMD Open | | 2020 | 220 | 121 | ||
| Mini-Review: Human Microbiome and Rheumatic Diseases | Frontiers in cellular and infection microbiology | | 2020 | 170 | 119 | ||
| The role of nutritional factors and intestinal microbiota in rheumatoid arthritis development | Nutrients | | 2020 | 153 | 136 | ||
| Transplantation de microbiote fécal : état actuel et perspectives | Revue médicale suisse | | 2019 | 295 | 4 | ||
| Intestinal dysbiosis in RA development: difficulty of establishing causality. Response to: 'Non-causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study' by Inamo | Annals of the Rheumatic Diseases | | 2019 | 319 | 4 |
